|
Market Closed -
Toronto S.E.
23:42:34 20/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 31.43 CAD | +2.01% |
|
+3.29% | +24.28% |
| 10-19 | Gilead Sciences, Inc. Presents New Findings From Its HIV And Antiviral Research And Development Programs At IDWeek 2026 | CI |
| 10-19 | Gilead's pill succeeds in mid-stage bowel disease trial | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,106B | |||||
| 612B | |||||
| 500B | |||||
| 367B | |||||
| 354B |
Select your edition
All financial news and data tailored to specific country editions
